Pattern’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity to address the immune failure underpinning cancers. PPI-100 is a recently patented second generation of an earlier product that received regulatory approval and has proven safe & efficacious for several infectious disease indications in patients.
PPI-100 is readily manufacturable and can be used as a monotherapy or in combination therapy. PPI-100's Mechanism of Action entails activating dendritic cells and macrophages, thereby increasing antigen-presenting activities directed at tumor antigens and resulting in anti-cancer cytotoxic T-cells and long-term T-cell memory.
Based on extensive in vivo nonclinical and supporting clinical data, Pattern's clinical development activities are focused on a large, white space opportunity to address the overall >40% relapse rate in cancer patients 5 years following surgery. Its key upcoming milestones are the completion of the GMP manufacturing of its Phase 1 clinical material and the filing of an IND Application with the FDA, targeted for Q3 2024, which will result in a Phase 1-ready asset. Pattern works with MD Anderson, Massachusetts General Hospital, McGill University and others.
Company Details
- Employees
- 4
- Address
- Toronto, Ontario, Ca
- Phone
- 416-302-5155
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- patternpharma.com
- HQ
- Toronto, Ontario
Pattern Pharma Questions
Pattern Pharma's helpline number is 416-302-5155
Pattern Pharma's website is patternpharma.com
Pattern Pharma's LinkedIn profile is https://ca.linkedin.com/company/pattern-pharma
Pattern Pharma has
4 employees.
View email and phone details for 4
employees at Pattern Pharma.
Pattern Pharma's industry is
Biotechnology Research
Pattern Pharma's top competitors are
Juno Pharma Canada Inc.,
Youthbio Therapeutics Inc.,
Virica Biotech,
Forus Therapeutics Inc,
Hdax Therapeutics,
Satellos Bioscience,
Qurcan Therapeutics Inc.,
Vasomune Therapeutics, Inc.,
Intellistem Technologies Inc.,
Juno Pharmaceuticals.
Pattern Pharma's support email address is info@patternpharma.com
Pattern Pharma's categories are Biotechnology Research
